Shafi Irfan, Hassan Abubakar A I, Akers Katherine G, Bashir Riyaz, Alkhouli Mohamad, Weinberger Jarret J, Abidov Aiden
Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, USA.
Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, USA.
Int J Cardiol. 2020 Sep 15;315:29-35. doi: 10.1016/j.ijcard.2020.05.017. Epub 2020 May 8.
Although congenital vena cava (CVC) anomalies in adults have implications for surgical and radiological interventions, the literature is scare and disparate. The aim of this systematic review was to assess cardiovascular clinical and procedural implications of CVC anomalies in adults without congenital heart disease.
We searched PubMed and EMBASE from database conception through October 2018 for English-language studies describing the epidemiology of CVC anomalies or their clinical or procedural implications in humans. Two independent reviewers screened 7093 records and identified 16 relevant studies. We found two major implications of CVC anomalies: 1) congenital inferior vena cava (CIVC) anomalies are associated with a 50-100-fold higher risk of deep venous thrombosis, particularly among younger patients, and 2) persistent left superior vena cava (PLSVC) is associated with a 2-3-fold higher risk of supraventricular arrhythmias. PLSVC also poses technical challenges to cardiovascular electronic device implantation, requiring alterations in surgical approach and lengthening procedure and X-ray exposure times. Due to the large disparity in reported prevalence rates of CIVC anomalies, we performed a meta-analysis of CIVC anomaly prevalence including 8 studies, which showed a weighted prevalence of 6.8% (95% CI, 4.5-9.2%).
These findings challenge the notion that CVC anomalies are rare and asymptomatic in adults. Rather, the literature indicates that CVC anomalies are not uncommon and have important clinical and procedural implications. To further understand the prevalence and implications of CVC anomalies, a robust US population-based study and nationwide registry is warranted in the current era of venous interventions.
尽管成人先天性腔静脉(CVC)异常对手术和放射学干预有影响,但相关文献稀少且分散。本系统评价的目的是评估无先天性心脏病的成人CVC异常的心血管临床及操作方面的影响。
我们检索了从数据库建立至2018年10月的PubMed和EMBASE数据库,查找描述CVC异常流行病学或其在人类中的临床或操作影响的英文研究。两名独立评审员筛选了7093条记录,确定了16项相关研究。我们发现CVC异常有两个主要影响:1)先天性下腔静脉(CIVC)异常与深静脉血栓形成风险高50至100倍相关,尤其是在年轻患者中;2)永存左上腔静脉(PLSVC)与室上性心律失常风险高2至3倍相关。PLSVC也给心血管电子设备植入带来技术挑战,需要改变手术方法、延长手术及X线暴露时间。由于报告的CIVC异常患病率差异很大,我们对包括8项研究的CIVC异常患病率进行了荟萃分析,结果显示加权患病率为6.8%(95%CI,4.5 - 9.2%)。
这些发现挑战了成人CVC异常罕见且无症状的观念。相反,文献表明CVC异常并不少见,且具有重要的临床和操作意义。为进一步了解CVC异常的患病率及影响,在当前静脉干预时代,有必要开展一项基于美国人群的有力研究及全国性登记。